ARDX
Ardelyx, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Ardelyx has 2 disclosed suppliers and 4 disclosed customers in SEC filings.
Last report7 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−17.86%
vs ±14.2% implied · ×1.25
shaded = implied · ▲▼ = realized
Largest filed tie
—
SentenceWe supply IBSRELA drug product packaged for the Canadian market to Knight to satisfy Knight's commercial needs.
ARDX 10-Kaccession 0001437402-26-000013
SentenceWe supply tenapanor drug substance to satisfy Kyowa Kirin's commercial needs.
ARDX 10-Kaccession 0001437402-26-000013
SentenceWe have an exclusive license agreement with Fosun Pharma for the development and commercialization of tenapanor in China for both hyperphosphatemia and IBS-C.
ARDX 10-Kaccession 0001437402-26-000013
Sentence
We have an exclusive license agreement with Knight for the development, commercialization and distribution of tenapanor in Canada for hyperphosphatemia and IBS-C.
ARDX 10-Kaccession 0001437402-26-000013
SentenceWe have an exclusive license agreement with Kyowa Kirin for the development, commercialization and distribution of tenapanor in Japan for cardiorenal indications.
ARDX 10-Kaccession 0001437402-26-000013
SentenceWe have an exclusive license agreement with METiS for the development and commercialization of a portfolio of TGR5 agonist compounds that we discovered and developed for all therapeutic areas.
ARDX 10-Kaccession 0001437402-26-000013
Ardelyx, Inc.
3.03
Expected move
Inputsspot 3.03exp Nov 20ATM strike 3ATM straddle 0.50IV 87%